首页 >
法规速递
-
Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments-2025/10/22
2025-10-24查看详情 > -
Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure-2025/11/26
2025-11-27查看详情 > -
Page: Medicine shortages and availability issues: guidance for companies-2025/12/17
2025-12-18查看详情 > -
Document: Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC)-2026/2/3
2026-02-04查看详情 > -
Document: Agenda of the CVMP meeting 10-12 March 2026-2026/3/11
2026-03-12查看详情 > -
Page: PRIME: priority medicines-2026/4/9
2026-04-10查看详情 > -
Page: Accelerating Clinical Trials in the EU (ACT EU)-2026/5/27
2026-05-28查看详情 > -
Document: Female contraceptive - Notified Body 0123 - 08/05/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)-2026/7/10
2026-07-11查看详情 > -
Document: Presentation - Fostering innovation in cardiovascular diseases with digitalisationand AI (K. Azer)-2026/8/14
2026-08-17查看详情 > -
Regulatory and procedural guideline: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes (updated)-2022/12/21
2022-12-21查看详情 >
